Tag Archives: Sputnik-V

Sinovac COVID-19 Vaccine Available To Brazilians In December

The governor of Brazil’s São Paulo State said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have shown promising results and it may be available to Brazilians as early as December.
Governor João Dória added that Phase 2 trials of the potential vaccine had shown an immune response of 98% in the elderly. Some 9,000 Brazilians are participating in the Sinovac vaccine trials, which are being conducted by the Butantan Institute in Sao Paulo city, the State capital. Brazil, which has the third worst outbreak of the novel coronavirus in the world after the United States and India, has become a testing ground for at least two vaccine candidates.

Brazil trials of Sinovac COVID-19 vaccine show promising results
One such vaccine is being developed by AstraZeneca, which has had to pause global trials after an unexplained illness in a participant in Britain. At the start of next year, Phase 3 trials of Russia’s “Sputnik-VCOVID-19 vaccine will also be conducted on 10,000 volunteers in Brazil in partnership with the State of Paraná’s Technology Institute, known as Tecpar.

Source: https://timesofindia.indiatimes.com/

Coronavirus: Russian vaccine shows signs of immune response

Russian scientists have published the first report on their coronavirus vaccine, saying early tests showed signs of an immune response.
The report published by medical journal The Lancet said every participant developed antibodies to fight the virus and had no serious side effects. Russia licensed the vaccine for local use in August, the first country to do so and before data had been published.

Experts say the trials were too small to prove effectiveness and safety. But Moscow has hailed the results as an answer to critics. Some Western experts have raised concerns about the speed of Russia’s work, suggesting that researchers might be cutting corners.

Last month, President Vladimir Putin said the vaccine had passed all the required checks and that one of his own daughters had been given it. Two trials of the vaccine, named Sputnik-V, were conducted between June and July, The Lancet paper said. Each involved 38 healthy volunteers who were given a dose of the vaccine and then a booster vaccine three weeks later.
The participants – aged between 18 and 60 – were monitored for 42 days and all of them developed antibodies within three weeks. Among the most common side effects were headaches and joint pain. The trials were open label and not randomised, meaning there was no placebo and the volunteers were aware they were receiving the vaccine.

https://www.bbc.com/

Coronavirus: Sputnik-V Vaccine Has Been Approved For Use

Russian President Vladimir Putin has said a locally developed vaccine for Covid-19 has been given regulatory approval after less than two months of testing on humans. Mr Putin said the vaccine had passed all the required checks, adding that his daughter had already been given it. Officials have said they plan to start mass vaccination in October.

Experts have raised concerns about the speed of Russia‘s work, suggesting that researchers might be cutting corners. Amid fears that safety could have been compromised, the World Health Organization (WHO) urged Russia last week to follow international guidelines for producing a vaccine against Covid-19. On Tuesday, the WHO said it had been in talks with Russian authorities about undertaking a review of the vaccine, which has been named Sputnik-V.

https://www.bbc.com/